Alastair Garfield sold $817K of Rhythm Pharmaceuticals (RYTM)

Executed Aug 13, disclosed Aug 17, 4 days later.

Value, as filed

$817K

6,963 sh across 3 lots

Executed

Aug 13

the trade date, as filed

Disclosed

Aug 17

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

AG Alastair Garfield Chief Scientific Officer profile →

Alastair Garfield (Chief Scientific Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Rhythm Pharmaceuticals, Inc. (RYTM). The largest single filing was $817K of RYTM (6,963 sh across 3 lots, as filed), executed Aug 13.

The name

RYTM Rhythm Pharmaceuticals, Inc. RYTM · Healthcare · 47 filings in 24 months ticker →

Healthcare · Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United State…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→